-->
Price Of Critical SMA Drug May Fall By 90% With Natco’s Generic Launch
Parents of children with spinal muscular atrophy (SMA) have welcomed Indian pharmaceutical company Natco's announcement.
Now fighting rare diseases will be economical
The government of India has come up with the policy of import duty exemption starting from 1 April 2023.
